SCH-546909

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSCH-546909
Drug Alias NameCDK2 inhibitors (Schering-Plough)cyclin dependent kinase 2 inhibitors (Schering- Plough)CDK2 inhibitors (Merck & Co)SCH-546909
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionCyclin-dependent kinase 2 degraders
TargetsCyclin-dependent kinase 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSchering-Plough Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSchering-Plough CorpMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A